Clinical Trials Browser

Observational × Maintenance × Other hematologic neoplasm × Clear all

NCT03847727 2020-01-18

Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell